The abstract is read at the publisher; the summary is JClub's.
Artificial intelligence–enabled small-molecule antibiotic discovery is expanding the size and diversity of explored chemical space to support novel antibacterial mechanisms of action.
- Why it matters: Antibiotic-resistant bacterial infections cause over 1 million deaths worldwide each year, creating an urgent need for new antibiotic classes, especially with new mechanisms.
- What they did: This Review synthesizes recent AI-driven advances across phenotypic discovery, mechanism-of-action elucidation, target-based discovery, de novo molecular design, and lead optimization.
- The result: These approaches are expected to broaden antibacterial agent repertoires and help uncover bacterial pathways and vulnerabilities suitable for therapeutic targeting.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.